DCCRX Mutual Fund

NAV$33.73

Fund Essentials - as of May 29, 2026

Net Assets
$21M
Expense Ratio
1.29%
Dividend Yield (Current)
3.58%
Holdings
141
Inception Date
Aug 1, 2005
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+19.28%
1 Year+30.21%
3 Year+13.33%
5 Year+8.44%
10 Year+11.75%

Asset Allocation

Stocks: 99.14%
Cash: 0.86%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
SMTCSemtechcorp.4.04%
MYRGMyr Group Inc2.02%
MODModine Manufacturing Company1.98%
AXSMAxsome Therapeutics, Inc.1.83%
TVTXTravere Therapeutics Inc1.78%
Top 10 Concentration: 19.78%Report Date: May 29, 2026
Download all 141 holdings for DCCRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.58%
Frequency
Annually
Latest Distribution
$1.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how DCCRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

DCCRX Mutual Fund Overview

DCCRX Mutual Fund (Nomura Small Cap Core Fund Class R) is managed by Nomura Asset Management Co Ltd with $20.8M in net assets. DCCRX expense ratio is 1.29%, holding 141 positions across sectors including Industrials, Financials, Health Care. Inception date: 2005-08-01.

DCCRX performance shows a YTD return of 19.28%. The 1-year return is 30.21% and the 5-year return is 8.44%. DCCRX dividend yield stands at 3.58%, paid annually.

DCCRX top holdings include Semtechcorp. (4.0%), Myr Group Inc (2.0%), Modine Manufacturing Company (2.0%), Axsome Therapeutics, Inc. (1.8%), Travere Therapeutics Inc (1.8%). View all DCCRX holdings, sector breakdown, or dividend history.

DCCRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DCCRX alternatives are available via the screener, along with tax-loss harvesting opportunities.